glp 1 and pet scan Distinctive detection of insulinoma using [18F]FB(ePEG12)12-exendin-4 PET/CT GLP-1 Drug Use May Create

Hany M, Zidan A, Ghozlan NA, et al

With potent glycemic control, near15% weight loss, and onceweekly dosing, zenagamtide is emerging as one of the most promising nextwave metabolic therapies in the rapidly evolving obesity and Type 2 Diabetes landscape

Bupropion is contraindicated in patients with seizure disorders, eating disorders (current or historical), abrupt discontinuation of alcohol or sedatives, or those taking monoamine oxidase inhibitors (MAOIs)

We havent had a medicine to deal with a problem this big and with such significantly positive results maybe ever

Contraindications cannot be enumerated because the human safety profile has not been studied